JP Stock MarketDetailed Quotes

4547 Kissei Pharmaceutical

Watchlist

3580
-55-1.51%

20min DelayTrading Feb 26 13:37 JST

171.52BMarket Cap14.52P/E (Static)

Kissei Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kissei Pharmaceutical Q3 2025 Earnings Date

Currency：JPYFeb 3, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	23.20B	--
		+11.12%
EPS	--	82.65	--
		+39.59%

Analyst Rating

Hold

Feb 4, 2025

Kissei Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2027/Q1	-- / 22.500B	--
--	2026/Q1	-- / 21.500B	--
Feb 3, 2025	2025/Q3	23.203B / --	--
Jul 30, 2024	2025/Q1	21.164B / 19.800B	--
Jan 30, 2024	2024/Q3	20.881B / --	--

DatePeriodRevenue/EstimateEarnings Call

--2027/Q1-- / 22.500B--

--2026/Q1-- / 21.500B--

Feb 3, 20252025/Q323.203B / ----

Jul 30, 20242025/Q121.164B / 19.800B--

Jan 30, 20242024/Q320.881B / ----

Unlock Free Earnings Estimates

Open Account

Kissei Pharmaceutical Earnings Reports

Kissei Pharmaceutical: Supplemental financial results for the 3rd quarter of the fiscal year ending March 31, 2025

Feb 3 01:30 ET

Kissei Pharmaceutical: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2025 [Japanese GAAP] (Consolidated)

Feb 3 01:30 ET

Kissei Pharmaceutical: Confirmation letter

Nov 12, 2024 23:01 ET

Kissei Pharmaceutical: Half Year Report - Term 80 (2024/04/01 - 2025/03/31)

Nov 12, 2024 23:00 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Analyst Rating

Updated: Feb 4, 2025

Hold

Strong Buy
0.00%
Buy
33.33%
Hold
66.67%
Underperform
0.00%
Sell
0.00%

Price Target

No Data